Bright Peak Therapeutics Announces $107 Million Series B Financing and Board Increase

Bright Peak Therapeutics Announces $107 Million Series B Financing and Board Increase

Ms. Siu is the chief operating officer in-residence at BridgeBio Pharma Inc., and former CFO at Eidos Therapeutics Inc., a BridgeBio subsidiary, where she transformed Eidos from a preclinical biotech start-up company to a late-stage clinical public company. Prior to that, she was the CBO at The Bluefield Project to Cure Frontotemporal Dementia, where she built a therapeutic pipeline and executed seven collaborations with the pharmaceutical industry. Earlier, she was senior director, corporate development at Global Blood Therapeutics, Inc. (GBT), and before that, a venture principal at Third Rock Ventures. Previously, Ms. Siu invested in life science companies in venture capital and private equity and held roles of increasing responsibility at Warburg Pincus LLC and Thomas, McNerney & Partners, LLC and began her career in healthcare banking at Bear, Stearns & Co. Inc. Ms. Siu holds an MBA from Harvard News School and a B.S. with distinction in cellular molecular biology and economics from the University of Michigan. Story continues On the Bright Peak board, Dr. Shawver and Ms. Siu join RA Capital’s Josh Resnick, M.D., and Michael Rosenzweig DVM, Ph.D., who joined in connection with the Series B financing, as well as existing board members Alex Mayweg, Ph.D., and Tom Woiwode, Ph.D., of Versant Ventures.

“The investment from this accomplished crossover syndicate underscores the enthusiasm for our platform and re-affirms our commitment to transform the therapeutic utility of cytokines to treat people with cancer and autoimmune diseases,” said Fredrik Wiklund, president and CEO of Bright Peak. “This capital will allow us to expand our Immunocytokine platform and advance our deep pipeline of programs across IL-2, IL-18 and IL-7.” Bright Peak uses a novel technology to chemically synthesize therapeutic cytokines by ligating together customized peptide segments. This proprietary technology provides unique flexibility to both tune and enhance cytokine biology through affinity modification and orthogonal, site-specific conjugation. The company’s platform also allows for the conjugation of its enhanced cytokines as payloads to certain antibodies, creating novel and proprietary “Bright Peak Immunocytokines.” These Immunocytokines will allow tissue- and cell-specific targeting of the cytokine payload with the added potential for synergistic efficacy through potency-enhancing avidity effects.

Also today, Bright Peak announced key additions to its board of directors with the appointments of independent directors Laura Shawver, Ph.D., and Christine Siu. Dr. Shawver, currently CEO of Silverback Therapeutics, is an industry veteran with an extensive scientific, translational and clinical background as well as a broad range of strategic expertise. Most recently, she was president and CEO of Synthorx, a developer of engineered cytokines for cancer and autoimmune disorders that was acquired by Sanofi in 2020 for $2.5 billion. She received her Ph.D. in pharmacology from the University of Iowa. Bright Peak Therapeutics, a biotechnology company developing next-generation cytokine immunotherapies to treat cancer and autoimmune disease, today announced that it raised $107 million in a Series B financing. The round was led by RA Capital, with participation by founding investor Versant Ventures and new investors Fidelity Management & Research Company, Invus, Qatar Investment Authority, funds and accounts managed by BlackRock, Alexandria Venture Investments and an undisclosed leading healthcare investment fund.

Bright Peak is a privately held biotechnology company based in San Diego, CA and Basel, Switzerland developing innovative cytokine therapeutics that are uniquely engineered to precisely tune and control desired biological properties. Using its proprietary Enhanced Design and Combine (EDC) chemistry platform, Bright Peak is developing an emerging portfolio of novel designer immunotherapies for the treatment of cancer and autoimmune diseases. Bright Peak is also pioneering a new category of “Bright Peak Immunocytokines” that simultaneously leverages the precision of antibody targeting with cytokine-mediated selective immune modulation in the desired microenvironment. View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005128/en/ About Bright Peak

“We warmly welcome Laura, Christine, Josh, and Michael to our Board of Directors. Their deep domain expertise and business acumen will serve as a tremendous resource to the Company,” said Dr. Mayweg. “We are pleased to lead a financing that will enable Bright Peak to broadly invest in its platform technologies, development programs, people, and, ultimately, towards delivering a pioneering new category of cytokine immunotherapies to patients in need,” said Dr. Resnick.

The News Highlights

  • Bright Peak Therapeutics Announces $107 Million Series B Financing and Board Increase
  • Check the latest News news updates and information about business, finance and more.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
Funding Fight: New Laws Take Money From Bay Restoration Fund |  News

Funding Fight: New Laws Take Money From Bay Restoration Fund | News

Two “non-significant” wastewater treatment plants will be upgraded in the coming fiscal year, according to MDE’s May 2021 report on pollution reduction goals. ...
Chardon Integrated Wellness unites mental and physical health |  Geauga County

Chardon Integrated Wellness unites mental and physical health | Geauga County

Chardon Integrated Wellness Center offers a variety of services intended to promote physical and mental well-being. However, the women persevered and opened at ...
Straw pulp mill working again |  The business

Straw pulp mill working again | The business

The plant, for example, will have short, 24-hour shutdowns at regular intervals to clean and maintain its equipment. During the outage, processes were changed ...
$800 million available for NY small businesses affected by the COVID-19 pandemic

$800 million available for NY small businesses affected by the COVID-19 pandemic

· Payroll costs Grants will be for a minimum of $5,000 and a maximum of $50,000. The grant amounts will be calculated based on a New York State business’ ...
Austin: Yet another reason to value locally managed nonprofit healthcare |  columnists

Austin: Yet another reason to value locally managed nonprofit healthcare | columnists

Source Money you spend on healthcare in our region stays in our region in the form of salaries, construction projects, tax dollars and more. Any surplus ...
G7 nations agree to increase climate finance, details lacking – World

G7 nations agree to increase climate finance, details lacking – World

The leaders signaled their desire to build a rival to Beijing’s multi-trillion-dollar Belt and Road initiative but the details were few and far between. There ...
Al Salam Bank signs financing agreement for Era Projects properties

Al Salam Bank signs financing agreement for Era Projects properties

Era Projects CEO Abdul Hussain Khudur said: “Through this Al Salam Bank deal, we are ensuring customers benefit from flexible financing facilities, thus ...
In March 2021, 50 hackers earned $832,135 each

In March 2021, 50 hackers earned $832,135 each

“Hacking just means to find a solution to a problem, and we already have a term for those doing this illegally: a cybercriminal,” Luke Tucker, vice-president ...
Illinois Health Officials Say More Than 9,200 Cases of COVID Linked to Variant Strains – Chicago News

Illinois Health Officials Say More Than 9,200 Cases of COVID Linked to Variant Strains – Chicago News

Source Illinois officials also reported 517 cases of coronavirus linked to the Epsilon variant, which was first discovered in California. Another 102 cases of ...
Westport business ready to reopen needs employees |  News

Westport business ready to reopen needs employees | News

After closing each of their establishments because of COVID, they laid off all their employees, which McZee says about 80 percent came back. McZee is no ...
Show next
Compsmag - Latest News from tech, business and health
Logo